Double Focus

North Korean leader Kim Jong-un is being discussed in coverage questioning a US nuclear double standard, with commentary arguing that Trump's friendly stance toward Kim contrasts sharply with Washington's hard line on Iran's nuclear programme. The debate focuses on why one nuclear-armed leader is treated as a negotiating partner while another faces pressure and threats, reigniting criticism of US non-proliferation policy.

Covid cases in Italy have doubled within a month, according to reports circulating in Italian media. Commentators note that for most people the current infection resembles a common cold, while so-called long Covid sequelae are now less frequent. Discussion is focused on whether the summer uptick warrants renewed caution or simply reflects an endemic seasonal virus.

A new double partnership has been announced, linking adult education initiatives with a Brussels-based radio station. The announcement pairs a learning-focused collaboration with a media collaboration in the Belgian capital. Details about the partners involved, the scope of the programmes, and the timeline have not yet been made widely available, so it is not clear what each partnership will deliver or who will benefit.

Bitcoin traders are debating whether the cryptocurrency is forming a double top pattern, which would typically signal a coming reversal, or whether the price will continue climbing. Discussion is focused on liquidation levels sitting just above the current price, with attention on US economic data due out later in the day that could determine the direction.

Oil exports from the Persian Gulf have recovered to levels seen earlier in 2025, after roughly doubling in September. The rebound points to a return to normal shipping activity in the region, which had been disrupted earlier in the year. Analysts are watching whether the recovery holds as global demand and regional tensions remain in focus.

Questions are being raised about whether Israel is held to a different standard at this year's UN General Assembly. Coverage of the annual gathering in New York has focused on how Israel is treated compared with other member states, prompting debate among diplomats and commentators over bias and double standards at the world body.

A randomized, double-blind, placebo-controlled trial published in Nature tested safiglipron, an oral small-molecule GLP-1 receptor agonist, in people with early type 2 diabetes. Unlike injectable GLP-1 drugs such as semaglutide, safiglipron is taken as a pill, which could make treatment easier to access. The publication is drawing attention as drugmakers race to develop oral alternatives to popular injectable weight and diabetes medications.